welcome
ScienceDaily

ScienceDaily

Health

Health

Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements

ScienceDaily
Summary
Nutrition label

79% Informative

Navtemadlin is an MDM2 inhibitor that can help to kill cancer cells by boosting the activity of p53, a protein that controls cell growth and induces cell death in response to DNA damage.

In lab experiments, the researchers found that navTemadlin was one of the best drugs at killing glioblastoma cells with intact, non-mutant p53.

VR Score

88

Informative language

93

Neutral language

63

Article tone

formal

Language

English

Language complexity

75

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.